FDA product code NRX: Complement 4d (C4d) And Complement Receptor 1 (Cr1)

NRX is the FDA product code for complement 4d (c4d) and complement receptor 1 (cr1). It is a Class II device, regulated under 21 CFR 866.5820 and reviewed by the Immunology panel. Devices under NRX reach the market by 510(k); FDA lists no cleared 510(k)s for it.

Definition

The device is an indirect immunofluorescence assay utilizing monoclonal antibodies and flow cytometry in the quantitative determination of complement 4d (C4d) and complement receptor 1 (CR1) on the surface of erythrocytes from EDTA anti-coagulated whole blood. The C4d and CR1 results are used in a ratio as an aid in the diagnosis of systemic lupus erythematosus.

Classification

FieldValue
Device nameComplement 4d (C4d) And Complement Receptor 1 (Cr1)
Device classClass II
Regulation21 CFR 866.5820
Review panelIM — Immunology
Medical specialtyImmunology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Recalls for NRX devices

openFDA lists no recalls for product code NRX.

Frequently asked questions

What is FDA product code NRX?

NRX is the FDA product code for complement 4d (c4d) and complement receptor 1 (cr1). It is a Class II device, regulated under 21 CFR 866.5820 and reviewed by the Immunology panel.

What device class is NRX?

Class II, regulation 21 CFR 866.5820. Typical premarket route: 510(k).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times